The goals of the iPLEDGE Program are to prevent fetal exposure to isotretinoin and to inform prescribers, pharmacists, and patients about isotretinoin's serious risks and safe-use conditions. The resources below present the program requirements and help you prepare and plan treatments with patients during the course of isotretinoin therapy.
You can click on each link to view the material online. Upon clicking on a link, each file will be launched in a new browser window. To view these PDF files, you will need Acrobat®Reader®.
For more information about the specific brands of isotretinoin, call the individual manufacturers at these numbers.
|Product Name||Company||Phone Number|
|Amnesteem®||Mylan Pharmaceuticals Inc.||1-800-796-9526|
|Claravis||Teva Pharmaceuticals USA, Inc.||1-800-227-7522|
|Absorica®||Sun Pharmaceutical Industries, Inc.||1-800-406-7984|
|Zenatane™||Dr. Reddy's Laboratories, Ltd.||1-888-375-3784|
|Amneal isotretinoin||Amneal Pharmaceuticals, LLC||1-877-835-5472|